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Introduction. Rheumatoid arthritis (RA) can involve the incudomalleolar or incudostapedial articulations. Objective.T ok n o wt h e
punctualprevalenceofaudiologicalalterationsinpatientswithRA.PatientsandMethods.RApatients andtheircontrols(Cs),were
evaluatedbyTonalAudiometry (AU);iftherewere alterationsintheairconduction(AC),boneconduction(BC),Logoaudiometry
(LG), and Tympanometry (T) were performed. Results. 45 RA patients and 45 Cs were evaluated. RA patients had 40% of bilateral
and 17.8% unilateral alteration versus Cs with 22.2% bilateral and 4.4% unilateral alteration versus Cs with 22.2% bilateral and
4.4% unilateral in AC audiometry. In conventional T (CT) As-type curves in patients with RA, there were 22LE (48.8%) and 26
RE (57.7%) versus Cs, there were16 RE (35.5%) and 20LE (44.4%). In High-frequency T (HFT): the 3B1G pattern in RA more
frequent versus Controls (Cs) in RE (P = .002 and LE (P = .01). There were no diﬀerences according to RA activity or RA disease
evolution.Conclusions. There is a greater tendency of auditive loss of As curves in CT (rigidity in ossicular chain) and of the 3B1G
p a t t e r ni nH F Ti nR A .
1.Introduction
Rheumatoidarthritis (RA)isasystemicdisease characterized
by inﬂammation of the synovial tissue with anatomical
and functional repercussion in the articulations [1, 2]. The
incudomalleolar and incudostapedial articulations are small
diarthrodial articulations [3, 4]; involvement of these articu-
lations has been reported in patients with RA [5–9]. Audio-
metric ﬁndings reported in these patients are conductive-
and sensory-type hypoacousias [8, 9]. Conductive-type
hypoacousia-associated factors comprise laxitude of the ear’s
transductor mechanisms [3] and rigidity of the middle
ear [9]; for neurosensory-type hypoacousia, immunological
alterations have been proposed, such as the presence of
speciﬁcantigensattheinnerearlevel,autoimmunecomplex-
related neurovascular damage, and lymphocyte B- and T-
mediatedautoimmunity[6,10]andtheuseofototoxicdrugs
such as methotrexate, hydroxychloroquine, and nonsteroidal
anti-inﬂammatory drugs (NSAIDS)[11–16].
RA is a pathology that causes musculoskeletal disability
andprobablyauditiveinvolvement.Theaimofthisstudywas
to establish the prevalence and type of auditive involvement
inpatientswith RA,and tocorrelatethisauditivedisfunction
with disease activity and duration.
2.Materialsand Methods
We carried out a descriptive and observational study of
paired cases and controls in a cohort. Cases were consecutive
patients at the out-patient consulting oﬃce of the Rheuma-
tology Department who fulﬁlled the following inclusion
criteria: classiﬁcation of RA according to the American
College of Rheumatology (ACR) [17], both genders, aging
20 to 65 years, and with voluntary acceptance to participate2 ISRN Rheumatology
in the study. The control group was made up of healthy
persons who accompanied the patients seen at the institute;
these individuals were age- and gender-paired with the cases.
Exclusion criteria for both groups comprised patients with
a history of infectious vascular middle ear and/or inner
ear pathology during the last 12 months, prior middle
ear surgery, exposure to occupational-type acoustic trauma,
head and neck neoplasias, cranial trauma, inner ear pathol-
ogy, antecedent of ototoxic drug use-related hypoacousia,
and RA-dissimilar systemic autoimmune disease dissimilar
in the group of cases. All participants signed a letter of
informed consent.
2.1. Variables Evaluated. We collected demographic data
on patients by means of a predesigned questionnaire and
evaluated RA activity with the Disease Activity Score (DAS)
28 [18], classifying activity as follows: inactive <2.6; slight
>2.6 and <3.2; moderate 3.2 and <5.1, severe >5.1. RA
diseaseevolutionwascategorizedinyears,andwecarriedout
the following audiological studies:
(i) tonalaudiometrywithAC40audiometry-typeequip-
ment from Interacoustics,
(a) by air conduction test, to obtain the auditive
threshold, considering auditive loss with a
threshold >20dB in one or more frequencies
[19, 20],
(b) bone conduction test, performed in patients
with some alteration in the air conduction
test, for later auditive loss classiﬁcation in
conductive (air-bone gap>15dB), sensory (gap
<15dB), or mixed conductive as well as sensory
frequencies [21],
(ii) logoaudiometry (LG), obtaining the word detectabil-
ity threshold, intelligibility threshold, and maximum
comprehension by means of the average threshold in
speech frequencies (500Hz and 1 and 2KHz) [21],
(iii) impedanciometry: to evaluate middle ear function
with the Ampliad brand model 775 (regulated by
ANSI 3.39) impedanciometry,
(a) 226-Hz tympanometry, classifying the results
according to Jerger based on compliance and
pressureinthefollowingcurves:typeA(normal
compliance and pressure), type As (diminished
compliance and normal pressure), type Ad
(increased compliance and normal pressure),
t y p eB( ﬂ a tt y m p a n o g r a m ) ,a n dt y p eC( d i s -
placed to negative pressures) [22].
(b) high-frequency tympanometry, classifying re-
s u l t sa c c o r d i n gt ot h em o d e lo fV a n h u y s ei n
patterns 1B1G and 3B1G (characteristics of
rigidity) and of 3B3Gand 5B3G(characteristics
of mass) [22].
2.2. Analysis of the Results. We conducted a descriptive
analysis of the demographic variables utilizing parametric
statistics: student t test for comparison of means, and χ2 test
for comparison of proportions. We carried out a subanalysis,
dividing the group into individuals >35 and <35 years of age
[23] to avoid degenerative hypoacousia-related classiﬁcation
bias and employing nonparametric statistics with the Mann-
Whitney U test for comparing diﬀerences of means and the
Fisher exact test for comparing categorical variables.
3.Results
We screened 53 patients with a diagnosis of RA: eight of
these patients were excluded due to Meniere’s syndrome,
eustachian tube dysfunction, and being aged >65 years. A
total of 45 patients with RAwere studied; these patients were
paired with 45 healthy subjects, who made up the control
group. In total, we studied 90 ears in each study group. In
Table 1, we observe the demographic characteristics of the
studied patients. A total of 91% of patients were of feminine
gender, with an average age of 44.1 years. High blood
pressure was the most frequently encountered comorbidity;
78% of patients with RA had >2 years of disease evolution.
The most commonly employed drug in patients with RA
was methotrexate in combination with a second drug; 24%
tooksteroidsand73%nonsteroidalanti-inﬂammatory drugs
(NSAIDS).
3.1. Tonal Audiometry: Air Conduction Test. In the group of
patients with RA, we found 19 subjects (42.2%) with normal
air conduction, 18 patients (40%) with bilateral alteration,
and eight patients with unilateral alteration versus the con-
trol group, in which we detected 33subjects(73.3%)without
alterations, 10 subjects (22.2%) with bilateral alteration,
and only two (4.4%) with unilateral alteration (P = .008)
(Figure 1). Patients with audiometric involvement in the RA
group were younger (mean age: 48.7 years) than the healthy
subjects (mean age: 55.3 years), with this being statistically
signiﬁcant (P = .02) (Table 2). On performing a subanalysis
by aﬀected ear, we found no diﬀerences in the proportion
of involvement between the right ear (RE) and left ear (LE)
(Table 2).
3.2. Mean Threshold by Frequency. Patients with RA tend
to have deterioration in high- and low-frequency auditive
thresholds compared with the controls, with this being sta-
tistically signiﬁcant at frequencies of 0.125, 0.250, and 8KHz
(P<. 01), without observing diﬀerences in intermediate
frequencies (0.5, 1, and 2KHz) (Figure 2).
3.3. Categorization by Age. On categorizing results by age,
in individuals aging <35 years, patients with RA had greater
deterioration in low-frequency auditive thresholds in com-
parison with controls, reaching statistical signiﬁcance in RE
at the frequency of 0.125 (P = .01) and in LE at frequencies
of 0.250 (P = .03) and 0.500KHz (P = .04); we observed
no diﬀerences in the remainder of frequencies. In the group
of patients with RA aging >35 years, there was a tendencyISRN Rheumatology 3
Table 1: Demographic characteristics of the populations under
study.
Characteristic Cases Controls
N 45 45
Gender
(feminine) 41 (91.1%) 41 (91.1%)
Age (years)
(mean ± SD)∗ 44.1 (11.9) 44.4 (12)
Comorbilidity (n)
Dyslipidemia (1) Dyslipidemia (1)
Systemic high blood
pressure (4)
Systemic high
blood pressure (2)
Diabetes mellitus (2)
Categorization by age
(years), n (%)
<35 12 (27) 13 (28.9)
>35 33 (73) 32 (71.1)
DAS 28, n (%)
Inactive 8 (18)
Slight activity 9 (20)
Moderate activity 19 (42)
Severe activity 9 (20)
RA evolution (years),
n (%)
<2 10 (22)
2–5 14 (31)
5–10 10 (22)
>10 11 (25)
Drugs utilized, n (%)
Methotrexate 35 (78)
Hydroxychloroquine/
chloroquine 24 (53)
Anti-TNF 7 (15)
Leﬂunomide 6 (13)
Sulfasalazine 6 (13)
Rituximab 5 (11)
Steroids 11 (24)
NSAID 33 (73)
∗Age diﬀerence between groups (P = 0.27).SD: standard deviation; Disease
Activity Score: DAS 28; Antitumoral necrosis Factor: Anti-TNF; NSAID:
nonsteroidal anti-inﬂammatory.
toward having auditive thresholds >8KHz, without this
reaching statistical signiﬁcance (Figure 3).
3.4. Auditive Involvement and RA Activity. In inactive
patientsaccordingtotheDAS28,wefoundelevationinmean
auditive thresholds in LE; in an analysis of only patients >35
years of age, these diﬀerences were maintained. We found no
diﬀerence in RE.
3.5. Categorization by Mean Disease Duration. No statistical
signiﬁcant diﬀerences were observed when air conduction
test alterations were correlated with mean disease duration.
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Figure 1 :A i rc o n d u c t i o nt e s ti ns t u d yg r o u p s .P r e v a l e n c eo f
hypoacusia was higher in RA patients compared with controls (P =
.008).
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Figure 2: Mean audition threshold obtained by frequency in both
studygroups.Themeanthresholdinfrequencies of0.125,0.250and
8KHz showed higher decrease in RA patients versus control group.
(P<. 01).
3.6. Tonal Audiometry: Bone Conduction Test. The propor-
tion of sensory hypoacousia was that which was most
frequently found in both groups, with the proportion of
patientswith RAat 45.5%versus24.4% inthecontrolgroup;
conductive- or mixed-type hypoacousia was only found in
some patients of the group with RA (Table 2).4 ISRN Rheumatology
Table 2: Audiological results.
Cases 45
n (%)
Controls 45
n (%)
P value
Age (years) of
patients with
hypoacousia
Mean ± SD
48.7 ±10.65 5 .3 ±8.3 .02
Audiometry
Normal 19 (42.2) 33 (73.3)
.008 Bilateral alteration 18 (40) 10 (22.2)
Unilateral alteration 8 (17.8) 2 (4.4)
Audiometric
alteration
Right ear 21 (46.7) 12 (26.6) .049
Left ear 23 (51.1) 10 (22.2) .004
Bone conduction
Sensory hypoacousia Right ear 19 (42.2) 12 (26.6) >.05
Left ear 22 (48.8) 10 (22.2) >.05
Conductive hypoacousia Right ear 1 (2.2) 0 >.05
Left ear 1 (2.2) 0 >.05
Mixed hypoacousia Right ear 1 (2.2) 0 >.05
Left ear 00 >.05
Logoaudiometry 2 (4.4) 0 >.05
Tympanometry
226Hz
Right ear Curve A 23 (51.1) 29 (64.4) .2
Curve As 22 (48.8) 16 (35.5)
Left ear Curve A 19 (42.2) 25 (55.5) .2
Curve As 26 (57.7) 20 (44.4)
High-frequency
tympanometry
Right ear 1B1G 32 (71.1) 43 (95.5) .002
3B1G 13 (28.8) 2 (4.4)
Left ear 1B1G 33 (73.3) 42 (93.3) .01
3B1G 12 (26.6) 3 (6.6)
3.7. Logoaudiometry. Only two patients (4.4%) of the group
with RA had maximum phonemic discrimination threshold
displacement.
3.8. 226-HZ Tympanometry. A total of 53.2% of patients
with RA had As-type curve (rigidity of the tympano-
ossicular complex) compared with control subjects (39.9%);
although we observed a tendencyfor ossicular-chain rigidity,
we found no statistically signiﬁcant diﬀerence (P = .2)
(Table 2).
3.9. High-Frequency Tympanometry. In both groups, the
mostfrequentlyencounteredpatternwas1B1G,althoughthe
group of patients with RA presented the 3B1G pattern with
greater frequency (27.7%) compared with the control group
(5.5%) (P = .002 in RE and P = .011 in LE, Table 2).
4.Discussion
The objective of the study was to compare the prevalence
o fa u d i t i v ea l t e r a t i o n si np a t i e n t sw i t hR Av e r s u sac o n t r o l
group. In our study, we found that patients with RA had a
greater prevalence of hypoacousia compared with healthy
subjects, thisissimilar to thatreported previouslyby Takatsu
et al., Raut et al., and Garc´ ıa Callejo et al. [4, 9, 24]; however,
in a study published recently by Halligan, the authors
observed no diﬀerence in the proportion of patients with
RA and healthy subjects who had hypoacousia and types of
auditive loss. One diﬀerence with our study is the age range
of the patients studied: the patients in the Halligan et al.
study ranged in age from 40 to 69 years; thus, the control
groupcouldhavehadaselection biasonhavingpatientswith
degenerative-type hypoacousia. The study did not conduct
age categorization in order to diminish this type of bias [5].
The prevalence of neurosensory hypoacousia was the
most frequent in our patients, this is similar to that reported
by Takatsu et al., Halligan et al., and Raut et al. Probably,
the cause of greater neurosensory hypoacousia can be due
to autoimmune-type etiologies, as well as to the use of
ototoxic drugs. The prevalence of conductive- or mixed-
type hypoacousia has been reported less frequently. In our
study, we found no healthy subject with these hypoacousia
types, probably because our inclusion and exclusion criteria
were strict; this is diﬀerent from other studies [4, 5, 9], in
which inclusion criteria were less strict, and this can result in
inappropriate selection of control subjects. For example, the
results of the study carried out by Salvinelli et al. reported
mixed hypoacousia as the most frequent type, diﬀering from
our study [6].
On analyzing thresholds obtained by frequency, we
observed that patients with RA tend to present auditiveISRN Rheumatology 5
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Figure 3: Mean hearing levels obtained by frequency by age group of both groups of subjects. In RA patients younger 35 years old in
frequencies 0.125KHz (P = .01) in right ear; 0.25KHz (P = .03) and 0.500KHz (P = .04) in left ear, showed higher decreased in mean
auditive threshold.
threshold deterioration; frequencies of 0.125 and 0.250KHz
are those that consistently have been aﬀected in our study as
well as in previous reports [4, 6, 9, 10, 25].
With the exception of the study conducted by Murdin
et al. in which the study subjects were <50 years of age [10],
the remainder ofthe studieshave beenperformed inpatients
with RA aging >50 years, in whom there is an age-related
degenerative factor. It is known that after the age of 65 years,
the prevalence of degenerative hypoacousia ranges from 20
to 40% [26, 27]; thus, we categorized our study groups as
<35and >35years of age, ﬁnding that patients with RAaging
<35 years had auditive thresholds at greater intensities in
lowfrequenciesascomparedwith controls,thisisstatistically
signiﬁcant at frequencies of 0.125, 0.250, and 0.500KHz. We
observed no diﬀerences in the remainder of frequencies; we
can associate this with a nearly imperceptible defect of air
transmission at the ossicular-chain level. This ﬁnding does
not persist in patients >35 years of age, which is probably
due to that there are degenerative-type factors that begin to
aﬀect patients with RA as well as healthy subjects. Therefore,
the diﬀerence is no longer evident of low frequencies, as we
observe in Figure 3. Now and then, in the group of patients
with RA <35 years of age, we observed a tendency toward
greater deterioration in auditive threshold at 8KHz, which
can indicate that the autoimmune process and the use of
ototoxicdrugscanaﬀectthesefrequencieswithoutbeingable
to isolate the degenerative process.
In earlier studies, attempts were made to relate hypoa-
cousia and RA disease activity; reports only included greater
auditive involvement in patients with active RA in compar-
ison with patients with inactive RA in the study performed
by Salvinelli et al. [6]. This was diﬀerent from the study
of Halligan et al. [5], who found no diﬀerences. In our
study, we found no diﬀerences between disease activity
and involvement at the ear level, although we observed
tendencies; but on categorizing our sample of patients with
RA, the subgroups were very small. We think that future
studies should include a greater number of patients and
should corroborate this ﬁnding, which is controversial.
In the LG, we only found displacement of maximum
phonetic discrimination thresholds at greater intensities in
two patients with RA and in no healthy subject, this is
because speech frequencies (500, 1,000, and 2,000Hz) were
found to be generally conserved in our study group.
In conventional tympanometry (226-Hz), we found that
patients with RA presented A-type curves more frequently
than the control group, this is compatible with greater
rigidity at the ossicular-chain level, as reported by Salvinelli
et al. [6]a n dT a k a t s ue ta l .[ 4]. In studies conducted by
Takatsu et al. [4]a n dR a u te ta l .[ 9], it is noteworthy that6 ISRN Rheumatology
the authors report type-Ad (increase in compliance) and
C-type curves (pressure displaced to negativity) of Jerger,
data that should not be present (mainly that of displacement
to negative pressures) because this could be suggestive of
middle ear pathology, as is the case of a tubal dysfunction
that can aﬀect the result in all audiometric studies. Halligan
et al. [5] report the tympanometric study only as normal
and abnormal, without specifying whether the abnormality
loss is due to alterations in compliance and/or pressure, and
they consider from 0.3 to 1.5cc as levels of normality in
compliance, when in adults normality ranges comprise 0.5
to 1.5cc.
In high-frequency tympanometry in both groups, we
foundpatternsofnormality(1-and3B1G),bothcharacteris-
tic of rigidity. However, it is evident that the 3B1G pattern is
more characteristic of patients with RA in comparison with
subjects in the control group.
In our study, we did not carry out an otoacoustic
emissions study, and the results in the previous studies are
controversial. The group of Halligan et al. [5]d i dn o tr e p o r t
diﬀerencesbetween patientswith RAand healthy subjects, in
contrast with the study conducted by Murdin et al. whose
authors reported a high proportion of patients with RA
who presented absence of reproducibility in transitory otoa-
coustic emissions; they consider this study to be a probable
predictor of hypoacousia in asymptomatic patients [10].
Thestrengthsofourstudyincludethenumberofpatients
evaluated and the diminution of the degenerative factor on
possessing a lower age range, as well as the subanalysis we
performed between individuals >35 and <35 years of age
and exclusion of middle ear and/or inner ear pathology.
However, in future studies, a sample calculation should be
made, taking into account the information available for
ﬁnding an association of hypoacousia in patients with RA
and conducting all of the systematic studies in the patients,
suchasboneconductiontest,becauseweonlyperformedthis
on ﬁnding auditive threshold deterioration, so as to be able
to evaluate the air-bone gap in the study groups, in order to
carry out prospective and longitudinal-type designs and to
include patients with early-onset RA, as well as to be able to
know the incidence of audiological involvement in patients
with RA, to evaluate risk factors, and to control variables
such as medical treatment and comorbidities.
5.Conclusions
In the present study, we found a prevalence of >57% air
conduction involvement in patients with RA, with sensory-
type hypoacousia being the most frequently encountered;
however, we also found conductive- and mixed-type hypoa-
cousia. These two hypoacousia types were exclusive ﬁndings
in patients with RA. Auditive thresholds in patients with
RA exhibit deterioration in relation to the control group.
In the 226-Hz tympanometry studies, there was diminished
compliance with greater frequency in patients with RA,
which can be translated into rigidity at the ossicular chain
level. In high-frequency tympanometries, we found that the
3B1G was the most prevalent pattern in patients with RA.
We found no relationship between RA disease evolution
time and disease activity with alteration in audiological
studies.
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